- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Rel B antibody [EP614Y] (AB33907)
Immunofluorescence staining of Raji cells with purified ab33907 at a working dilution of 1/100, counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077), used at a dilution of 1/1000. ab7291, a mouse anti-tubulin antibody (1/1000), was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse, 1/1000), shown in the top right hand panel. The cells were fixed in 4 % PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1, purified ab33907 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2, ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP614Y] (AB33907)
Overlay histogram showing Raji cells stained with unpurified ab33907 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab33907, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in Raji cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP614Y] (AB33907)
Overlay histogram showing Raji cells fixed in 80% methanol and stained with purified ab33907 at a dilution of 1/70 (red line). The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit at a dilution of 1/500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).
- IP
Lab
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (AB33907)
Rel B was immunoprecipitated from 0.35 mg of Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate with ab33907 at 1/30 dilution. Western blot was performed from the immunoprecipitate using 33907 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution. Lane 1 : Raji whole cell lysate 10 μg (Input). Lane 2 : ab33907 IP in Raji whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab33907 in Raji whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 180 seconds.
All lanes:
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (ab33907) at 1/1000 dilution
Lane 1:
Raji whole cell lysate at 10 µg
Lane 2:
ab33907 IP in Raji whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 62 kDa
Observed band size: 62 kDa
false
Exposure time: 180s
- IP
Unknown
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (AB33907)
ab33907 (purified) at 1/20 immunoprecipitating Rel B in 10 μg Daudi cell lysate (Lanes 1 and 2, observed at 70 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730). For western blotting, HRP Veriblot for IP (ab131366) was used for detection (1/1000). Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-Rel B antibody [EP614Y] (ab33907)
Predicted band size: 62 kDa
false
- WB
Unknown
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/20000 dilution
All lanes:
Raji Cell Lysate
Predicted band size: 62 kDa
Observed band size: 62 kDa
false
- WB
Lab
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/2000 dilution
Lane 1:
Raji cell lysate at 20 µg
Lane 2:
Daudi cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 62 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-Rel B antibody [EP614Y] (AB33907)
Lanes 1- 4 : Merged signal (red and green). Green - ab33907 observed at 70 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab33907 was shown to react with Rel B in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265948 (knockout cell lysate ab257635) was used. Wild-type HeLa and RELB knockout HeLa cell lysates were subjected to SDS-PAGE. ab33907 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Rel B antibody [EP614Y] (ab33907) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 40 µg
Lane 2:
RELB knockout HeLa cell lysate at 40 µg
Lane 2:
Western blot - Human RELB (Rel B) knockout HeLa cell line (<a href='/ko/products/cell-lines/human-relb-rel-b-knockout-hela-cell-line-ab265948'>ab265948</a>)
Lane 3:
Raji cell lysate at 40 µg
Lane 4:
LnCap cell lysate at 40 µg
Predicted band size: 62 kDa
Observed band size: 70 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (3)
-
Anti-Rel B antibody [EP614Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Rel B antibody [EP614Y]
-
578 PE
PE Anti-Rel B antibody [EP614Y]
Reactivity 정보
제품 세부 정보
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Rel B serves as a critical component of the alternative NF-κB signaling pathway. It often forms a complex with another NF-κB family member called p52. This complex controls the transcription of genes involved in the immune response cell survival and differentiation. Additionally Rel B contributes to the development of secondary lymphoid organs and modulation of immune responses.
Pathways
Rel B integrates into the non-canonical NF-κB signaling pathway also influencing the canonical pathway to a lesser extent. In the non-canonical pathway Rel B interacts with NIK and p100 to influence immune cell function. This involvement makes Rel B essential in processes like adaptive immunity and inflammatory responses. The protein p52 closely associates with Rel B aiding its activity in these pathways.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (6)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Signal transduction and targeted therapy 10:43 PubMed39865075
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1624 PubMed34926668
2021
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 22:e52032 PubMed34105235
2021
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 14:1553-1564 PubMed33688203
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 120:3978-3988 PubMed30378143
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 284:27857-65 PubMed19690169
2009
Applications
IP
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com